First prototype expected to be completed by the end of 2019
Shvabe Holding (part of Rostec State Corporation) and Peter the Great St. Petersburg Polytechnic University are working together to create the first Russian equipment for non-invasive tumour treatment.
The production of this new high-intensity focused ultrasound (HIFU) system will be organised in the Novosibirsk Instrument-making plant and first prototypes will be created by the end of 2019.
Non-invasive treatment is one of the safest ways to treat cancer. The HIFU system, that includes both hardware and software, will be designed for diagnostics and treatment of tumours in the mammary gland using focused high-intensity ultrasound. The system will consist of a power module, a medical stand with a monitor and control panel, a robotic manipulator unit, the ultrasound unit with a combined ultrasonic piezoelectric transducer for both diagnostics and treatment and the patient's seat with an immobiliser.
The first clinical tests are expected in 2020. After this, the project can obtain a registration certificate and start mass production.
"We see great potential for the supply of our high-tech medical equipment to highly-populated developing countries like India, China and the countries of Southeast Asia and Latin America," pointed Viktor Kladov, the Director for International Cooperation and Regional Policy Department of Rostec.
The project is financed by Novosibirsk Instrument-making plant, subsidiary of Shvabe Holding.
In the future, a whole new line of analogous devices might be created based on this project. These include devices intended for the treatment of tumours in the liver, prostate gland and brain.
Click here for the complete issue.